Logo image of XOG

Extraction Oil & Gas Inc (XOG) Stock Fundamental Analysis

NASDAQ:XOG - Nasdaq -

68.54  +1.91 (+2.87%)

Fundamental Rating

2

Overall XOG gets a fundamental rating of 2 out of 10. We evaluated XOG against 210 industry peers in the Oil, Gas & Consumable Fuels industry. XOG has a bad profitability rating. Also its financial health evaluation is rather negative. XOG has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

XOG had positive earnings in the past year.
XOG Yearly Net Income VS EBIT VS OCF VS FCFXOG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 500M -500M -1B

1.2 Ratios

Industry RankSector Rank
ROA -0.04%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XOG Yearly ROA, ROE, ROICXOG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 100 -100 -200 -300

1.3 Margins

Industry RankSector Rank
OM -3.63%
PM (TTM) -0.07%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XOG Yearly Profit, Operating, Gross MarginsXOG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 -100 -200

2

2. Health

2.1 Basic Checks

XOG has less shares outstanding than it did 1 year ago.
XOG has a better debt/assets ratio than last year.
XOG Yearly Shares OutstandingXOG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 50M 100M 150M
XOG Yearly Total Debt VS Total AssetsXOG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 1B 2B 3B 4B

2.2 Solvency

XOG has an Altman-Z score of 2.28. This is not the best score and indicates that XOG is in the grey zone with still only limited risk for bankruptcy at the moment.
XOG has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 2.28
ROIC/WACCN/A
WACCN/A
XOG Yearly LT Debt VS Equity VS FCFXOG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 1B -1B

2.3 Liquidity

XOG has a Current Ratio of 0.40. This is a bad value and indicates that XOG is not financially healthy enough and could expect problems in meeting its short term obligations.
XOG has a Quick Ratio of 0.40. This is a bad value and indicates that XOG is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.35
XOG Yearly Current Assets VS Current LiabilitesXOG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 200M 400M 600M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 366.67% over the past year.
XOG shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.39%.
XOG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.05% yearly.
EPS 1Y (TTM)366.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%147.69%
Revenue 1Y (TTM)22.39%
Revenue growth 3Y-2.63%
Revenue growth 5Y23.05%
Sales Q2Q%254.24%

3.2 Future

XOG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.52% yearly.
The Revenue is expected to grow by 0.51% on average over the next years.
EPS Next Y506.28%
EPS Next 2Y109.66%
EPS Next 3Y60.03%
EPS Next 5Y25.52%
Revenue Next Year65.89%
Revenue Next 2Y24.93%
Revenue Next 3Y9.39%
Revenue Next 5Y0.51%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
XOG Yearly Revenue VS EstimatesXOG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
XOG Yearly EPS VS EstimatesXOG Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.82 indicates a correct valuation of XOG.
Compared to an average S&P500 Price/Earnings ratio of 27.41, XOG is valued a bit cheaper.
The Price/Forward Earnings ratio is 7.17, which indicates a rather cheap valuation of XOG.
XOG's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.19.
Industry RankSector Rank
PE 13.82
Fwd PE 7.17
XOG Price Earnings VS Forward Price EarningsXOG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.33
XOG Per share dataXOG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

XOG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
XOG's earnings are expected to grow with 60.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y109.66%
EPS Next 3Y60.03%

0

5. Dividend

5.1 Amount

XOG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Extraction Oil & Gas Inc

NASDAQ:XOG (11/1/2021, 8:41:27 PM)

68.54

+1.91 (+2.87%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-08 2021-11-08
Earnings (Next)03-17 2022-03-17/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners200.24%
Ins Owner Change0%
Market Cap1.81B
Analysts76.67
Price Target72.42 (5.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.82
Fwd PE 7.17
P/S 2.09
P/FCF N/A
P/OCF N/A
P/B 2.66
P/tB N/A
EV/EBITDA 7.33
EPS(TTM)4.96
EY7.24%
EPS(NY)9.56
Fwd EY13.95%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS32.73
BVpS25.75
TBVpSN/A
PEG (NY)0.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.04%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -3.63%
PM (TTM) -0.07%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.4
Quick Ratio 0.35
Altman-Z 2.28
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)366.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%147.69%
EPS Next Y506.28%
EPS Next 2Y109.66%
EPS Next 3Y60.03%
EPS Next 5Y25.52%
Revenue 1Y (TTM)22.39%
Revenue growth 3Y-2.63%
Revenue growth 5Y23.05%
Sales Q2Q%254.24%
Revenue Next Year65.89%
Revenue Next 2Y24.93%
Revenue Next 3Y9.39%
Revenue Next 5Y0.51%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A